Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly L Gray

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Patient Preference and Adherence|November 8, 2019
Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?Woojung Lee, Shelly L Gray, Douglas Barthold, et al.
Journal of the American Geriatrics Society|November 19, 2011
Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomesDenise M Boudreau, Onchee Yu, Shelly L Gray, et al.
American Journal of Alzheimer'S Disease and Other Dementias|September 6, 2003
Community residential care: comparison of cognitively impaired and noncognitively impaired residentsJane B Tornatore, Susan C Hedrick, Jean H Sullivan, et al.
Journal of the American Geriatrics Society|July 12, 2002
Is the use of benzodiazepines associated with incident disability?Shelly L Gray, Andrea Z LaCroix, David Blough, et al.
Preventive Medicine Reports|February 6, 2020
Beliefs about benefits and harms of medications and supplements for brain healthZachary A Marcum, Sarah D Hohl, Douglas Barthold, et al.
American Journal of Health Behavior|February 28, 2019
Brain Health and Dementia Prevention: A Mixed-method AnalysisZachary A Marcum, Sarah D Hohl, Shelly L Gray, et al.
The American Journal of Geriatric Pharmacotherapy|November 24, 2004
Is antioxidant use protective of cognitive function in the community-dwelling elderly?Shelly L Gray, Joseph T Hanlon, Lawrence R Landerman, et al.
Patient Education and Counseling|June 29, 2021
Barriers and enablers of older adults initiating a deprescribing conversationNagham J Ailabouni, Kristie Rebecca Weir, Emily Reeve, et al.
Journal of the American Geriatrics Society|December 22, 2017
Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older AdultsShelly L Gray, Laura A Hart, Subashan Perera, et al.
JAMA Network Open|July 10, 2025
Cumulative Anticholinergic Exposure and Change in Gait Speed and Grip Strength in Older AdultsShelly L Gray, Yu-Ru Su, Tesfahun C Eshetie, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Patient Preference and Adherence|November 8, 2019
Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?Woojung Lee, Shelly L Gray, Douglas Barthold, et al.
Journal of the American Geriatrics Society|November 19, 2011
Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomesDenise M Boudreau, Onchee Yu, Shelly L Gray, et al.
American Journal of Alzheimer'S Disease and Other Dementias|September 6, 2003
Community residential care: comparison of cognitively impaired and noncognitively impaired residentsJane B Tornatore, Susan C Hedrick, Jean H Sullivan, et al.
Journal of the American Geriatrics Society|July 12, 2002
Is the use of benzodiazepines associated with incident disability?Shelly L Gray, Andrea Z LaCroix, David Blough, et al.
Preventive Medicine Reports|February 6, 2020
Beliefs about benefits and harms of medications and supplements for brain healthZachary A Marcum, Sarah D Hohl, Douglas Barthold, et al.
American Journal of Health Behavior|February 28, 2019
Brain Health and Dementia Prevention: A Mixed-method AnalysisZachary A Marcum, Sarah D Hohl, Shelly L Gray, et al.
The American Journal of Geriatric Pharmacotherapy|November 24, 2004
Is antioxidant use protective of cognitive function in the community-dwelling elderly?Shelly L Gray, Joseph T Hanlon, Lawrence R Landerman, et al.
Patient Education and Counseling|June 29, 2021
Barriers and enablers of older adults initiating a deprescribing conversationNagham J Ailabouni, Kristie Rebecca Weir, Emily Reeve, et al.
Journal of the American Geriatrics Society|December 22, 2017
Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older AdultsShelly L Gray, Laura A Hart, Subashan Perera, et al.
JAMA Network Open|July 10, 2025
Cumulative Anticholinergic Exposure and Change in Gait Speed and Grip Strength in Older AdultsShelly L Gray, Yu-Ru Su, Tesfahun C Eshetie, et al.
Pageof 14